Given RadNet's recent partnership to advance AI in healthcare and positive earnings report showing significant revenue growth, I believe RDNT is well-positioned for continued gains. The upward revisions in analyst ratings further reinforce my optimism, making this purchase a strategic decision to capitalize on the company's momentum.